Deterministic Verification
for MDR/IVDR
Documentation

Catch unsupported claims, weak evidence links, numerical mismatches and cross-document gaps before Notified Body review.

Deterministic checks

Client Satisfaction Rate

Traceable outputs

Traceable outputs

Human-reviewed findings

Human-reviewed findings

Our Offer

One Audit Across Your MDR/IVDR Evidence Package

Start with one CER or PMCF package. Receive a claim-to-source audit in 5 business days.

CER

PMCF

PMS / PSUR

SSCP

GSPR

NB
Responses

Cross-Document Consistency

Detailed claim-level audit

Secured and confidential

Secured and confidential

How it works

Evidence Issues That Trigger Reviewer Questions

Evidence Issues That Trigger Reviewer Questions

LocusLab checks MDR/IVDR evidence packages for unsupported claims, weak source links, outdated evidence, numerical mismatches and cross-document inconsistencies.

LocusLab checks MDR/IVDR evidence packages for unsupported claims, weak source links, outdated evidence, numerical mismatches and cross-document inconsistencies.

Finding ECO03 — Critical

Claim overstates PMCF support: cited
section confirms safety monitoring, but
does not demonstrate clinical benefit
in the target population.

Clinical Evidence Gaps

Insufficient evidence for an intended purpose, indication, population, device variant, or benefit-risk conclusion.

AI Agent

Unsupported claims

Claims that are not sufficiently backed by the cited clinical, scientific or post-market evidence.

The primary endpoint, defined as the proportion of patients achieving a ≥50% reduction in total score from baseline at Week 24, was met. In the intent-to-treat (ITT) population (n=312), 68.4% of patients in the Compound X arm achieved the primary endpoint compared to 31.2% in the placebo arm (p<0.001). The between-group difference was 37.2 percentage points (95% CI: 29.8–44.6).

Cross-document gaps

Misalignment between CER, PMCF, PMS, SSCP, GSPR mappings or NB response materials.

Comparison

CER v4

92.4%

PMCF v2

81.7%

Numerical inconsistencies

Conflicting percentages, totals, dates, thresholds, population counts or study figures.

CER_14.1_v1.docx

PMCF_14.2_v2.pdf

SSCP_16.2_v1.docx

Outdated references

Stale sources, obsolete tables or evidence that no longer matches the current version of the document.

Weak evidence links

Statements where a source is cited, but the source does not clearly support the exact claim being made.

Our Process

Deterministic Review.
Actionable Output.

Deterministic Review.
Actionable Output.

We produce a structured a claim-to-source matrix, a discrepancy report, a severity ranking, and remediation notes that your RA, clinical, or QA team can review before submission, update, or remediation.

We produce a structured a claim-to-source matrix, a discrepancy report, a severity ranking, and remediation notes that your RA, clinical, or QA team can review before submission, update, or remediation.

01

Scope definition

We agree on one final or near-final CER/PMCF package to review. Redacted or synthetic material can be used for a first pilot.

01

Scope definition

We agree on one final or near-final CER/PMCF package to review. Redacted or synthetic material can be used for a first pilot.

02

Evidence audit

LocusLab runs deterministic, provenance-preserving checks to map claims to sources, compare figures, and identify weak or missing evidence links.

02

Evidence audit

LocusLab runs deterministic, provenance-preserving checks to map claims to sources, compare figures, and identify weak or missing evidence links.

03

Audit Review

We walk through the audit output with your RA, clinical, or QA team so findings can be challenged, clarified, and prioritized before final delivery.

03

Audit Review

We walk through the audit output with your RA, clinical, or QA team so findings can be challenged, clarified, and prioritized before final delivery.

04

Deliver the audit package

Final report with traceable findings, source locations and remediation notes for expert review.

04

Deliver the audit package

Final report with traceable findings, source locations and remediation notes for expert review.

Our Engagements

Designed for Sensitive Regulatory Documents.

We handle sensitive regulatory documents with confidentiality, and a deliberately limited scope.

No model training

Client documents are not used to train shared models. Pilot scopes can include contractual deletion/retention limits, separated workspaces, and controlled processing options.

Redacted pilot available

Start with a redacted CER/PMCF package or a synthetic sample.

No platform rollout

Start with one bounded audit.

Human judgment preserved

LocusLab surfaces evidence issues for expert review. Your RA, clinical or QA team remains in control of the final judgment.

Let’s Connect

De-Risk Your MDR/IVDR Package

Schedule a brief consultation to learn how LocusLab can improve the robustness of your MDR/IVDR dossier.

Let’s Connect

De-Risk Your MDR/IVDR Package

We're working with a small number of Phase II/III biotech teams as design partners. If your team is managing QC manually today, let's talk.

Let’s Connect

De-Risk Your MDR/IVDR Package

Schedule a brief consultation to learn how LocusLab can improve the robustness of your MDR/IVDR dossier.